Achieve Life Sciences, Inc. (ACHV) Earnings History
Annual and quarterly earnings data from 1994 to 2025
Loading earnings history...
ACHV EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ACHV Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export ACHV earnings history in CSV or JSON format
Free sign-in required to download data
Achieve Life Sciences, Inc. (ACHV) Earnings Overview
As of May 8, 2026, Achieve Life Sciences, Inc. (ACHV) reported trailing twelve-month net income of -$52M, reflecting -0.8% year-over-year growth. The company earned $-1.51 per diluted share over the past four quarters.
Looking at the long-term picture, ACHV's historical earnings data spans multiple years. The company achieved its highest annual net income of $5M in fiscal 2009.
Achieve Life Sciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PTGX (-$115M net income, -282.8% margin), ATAI (-$154M net income, -48464.0% margin), GFAI (-$24M net income, -16.1% margin), ACHV has comparable earnings metrics. Compare ACHV vs PTGX →
ACHV Earnings vs Peers
Earnings metrics vs comparable public companies
ACHV Historical Earnings Data (1994–2025)
32 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$55M | -37.2% | $0 | $-1.25 | - | - |
| 2024 | -$40M | -33.6% | -$39M | $-1.24 | - | - |
| 2023 | -$30M | +29.6% | -$27M | $-1.50 | - | - |
| 2022 | -$42M | -27.7% | -$41M | $-3.95 | - | - |
| 2021 | -$33M | -126.1% | -$33M | $-4.05 | - | - |
| 2020 | -$15M | +10.6% | -$15M | $-5.39 | - | - |
| 2019 | -$16M | -29.2% | -$17M | $-39.15 | - | - |
| 2018 | -$13M | -19.9% | -$13M | $-72.29 | - | - |
| 2017 | -$11M | +47.4% | -$7M | $-441.47 | - | - |
| 2016 | -$20M | -19.8% | -$21M | $-1474.98 | -397.6% | -418.6% |
See ACHV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ACHV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ACHV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonACHV — Frequently Asked Questions
Quick answers to the most common questions about buying ACHV stock.
Is ACHV growing earnings?
ACHV EPS of $-1.51 reflects slowing growth at -0.8%, below the 5-year CAGR of N/A. TTM net income is $-52M. Expansion rate has moderated.
What are ACHV's profit margins?
Achieve Life Sciences, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are ACHV's earnings?
ACHV earnings data spans 1994-2025. The current earnings trend is -0.8% YoY. Historical data enables comparison across business cycles.